In The News
September 2020
Covid-19
Approximately 1.6% of adults with COVID-19 who visited one of two New York City Academic Medical Centers Emergency Departments or were hospitalized, experienced ischemic stroke, a higher rate than influenza.
(source)September 2018
NeuroNews
Preliminary results of the Hydrogel Endovascular Aneurysm Treatment (HEAT) trial were announced at SNIS this year and suggest decrease recurrence rate with hydrogel coils.
(source)March 2018
Johnson and Johnson
Johnson and Johnson's Codman Neuro undergoing rebranding under Cerenovus while acquiring Pulsar Vascular (PulseRider®) and Neuravi (EmboTrap®).
BALT
Balt International acquires Blockade Medical and undergoes rebranding as Balt USA (www.balt-usa.com)
February 2017
GREAT Trial
Christian Taschner, MD, PhD and others at University Hospital Freiburg in Germany reported decreased adverse outcomes with second generation hydrogel coils (Microvention Hydrosoft or Hydroframe) compared with standard platinum coils.
January 2017
#1in50 Campaign
Help support the Brain Aneurysm Foundation (www.bafound.org) with their new campaign focused on education and research for the 1 in 50 people who have a brain aneurysm.
